The B/S is the near term issue....other than the science of course. Update on P2 due out in Feb...I think.
Stock still in long term downtrend, but it has made some huge % moves before...like From 2 cents in 12/2008 ti 26 cents by 2/2010...14 months!
Now finally, we are getting closer and closer to results and the stock is beginning to bubble. I can't help but think that their drug could be used in a cocktail type approach to multiple cancer treatments. Step at a time I know...and at least we're walking at the moment...running next if results good.
News 
Market Data 
Discover 
